TrialPanorama/TrialPanorama-database huggingface dataset:
Study 18846045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18851761 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18851871 — Predictive Biomarker (PRD): WAP four-disulfide core domain protein 2
Genes: WFDC2; HE4; WAP5
Study 18851871 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 18922099 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 18922099 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 18926148 — Surrogate Endpoint (SUR): Serum creatinine
Study 18926148 — Surrogate Endpoint (SUR): Blood pressure
Study 18926148 — Surrogate Endpoint (SUR): Serum sodium
Study 18926148 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18942885 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18942885 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18942885 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 18950508 — Surrogate Endpoint (SUR): Blood pressure
Study 18952896 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 18952896 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 18952896 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18952896 — Safety Biomarker (SAF): Reactive oxygen species
Study 18955445 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 18955445 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 18955445 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 18971421 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 18974373 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 18977647 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 18983669 — Surrogate Endpoint (SUR): Bone mineral density
Study 19020433 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19020749 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 19020749 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 19020749 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 19020749 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 19029442 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 19031925 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 19032759 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 19032759 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19037628 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 19054318 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 19064724 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 19068141 — Surrogate Endpoint (SUR): Blood pressure
Study 19087222 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 19092346 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 19103636 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 19106083 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 19106083 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study 19106083 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 19106083 — Predictive Biomarker (PRD): P2RY12 mRNA
Genes: P2RY12; HORK3
Study 19106083 — Predictive Biomarker (PRD): ITGB3 mRNA
Genes: ITGB3; GP3A
Study 19106084 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 19109557 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study 19117345 — Predictive Biomarker (PRD): ELN mRNA
Genes: ELN
Study 19118066 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 19131464 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19131464 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 19141127 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 19141127 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19141127 — Predictive Biomarker (PRD): SLC7A5 mRNA
Genes: SLC7A5; CD98LC; LAT1; MPE16
Study 19141127 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 19141127 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 19141590 — Surrogate Endpoint (SUR): Bone mineral density
Study 19143927 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 19144982 — Predictive Biomarker (PRD): AFF1 mRNA
Genes: AFF1; AF4; FEL; MLLT2; PBM1
Study 19144982 — Predictive Biomarker (PRD): TET1 mRNA
Genes: TET1; CXXC6; KIAA1676; LCX
Study 19153124 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19153124 — Predictive Biomarker (PRD): Hormone receptor
Study 19153274 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 19153830 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 19155249 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19155319 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 19155319 — Surrogate Endpoint (SUR): Blood pressure
Study 19158205 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study 19167685 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 19167685 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19167838 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 19167838 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 19168793 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 19168793 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 19168793 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study 19170709 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 19177575 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 19179301 — Predictive Biomarker (PRD): CR1 mRNA
Genes: CR1; C3BR
Study 19179314 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 19181452 — Predictive Biomarker (PRD): Hormone receptor
Study 19181644 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19181644 — Safety Biomarker (SAF): Interleukin 1
Study 19181644 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19182205 — Predictive Biomarker (PRD): Chromosome 17p
Study 19182205 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 19191652 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 19196892 — Surrogate Endpoint (SUR): Serum creatinine
Study 19204302 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19207166 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19207166 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 19210163 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 19210163 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 19217019 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 19217176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19223069 — Surrogate Endpoint (SUR): Blood pressure
Study 19228761 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19228761 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 19228761 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 19237390 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 19237390 — Safety Biomarker (SAF): BDNF
Study 19238148 — Pharmacodynamic Biomarker (PDY): Cyclin-dependent kinase 1
Genes: CDK1; CDC2; CDC28A; CDKN1; P34CDC2
Study 19240154 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 19245964 — Surrogate Endpoint (SUR): Serum triglycerides
Study 19245964 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 19246107 — Surrogate Endpoint (SUR): Blood pressure
Study 19264750 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 19267708 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 19268724 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 19268724 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19270751 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19273449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19273449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19277125 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 19277125 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 19286996 — Predictive Biomarker (PRD): NFATC2 mRNA
Genes: NFATC2; NFAT1; NFATP
Study 19286996 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19286996 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 19287552 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 19297571 — Surrogate Endpoint (SUR): Blood pressure
Study 19297571 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 19299430 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19299430 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19304957 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study 19317607 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19331677 — Surrogate Endpoint (SUR): Blood pressure
Study 19333404 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 19339093 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 19339913 — Predictive Biomarker (PRD): MTRR mRNA
Genes: MTRR
Study 19339913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 19339913 — Safety Biomarker (SAF): Reactive oxygen species
Study 19344074 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 19345439 — Monitoring Biomarker (MOI): HBV DNA
Study 19348685 — Predictive Biomarker (PRD): PRKRA mRNA
Genes: PRKRA; PACT; RAX; HSD-14; HSD14
Study 19357147 — Surrogate Endpoint (SUR): Blood pressure
Study 19358725 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19364933 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 19364977 — Surrogate Endpoint (SUR): Blood pressure
Study 19375217 — Surrogate Endpoint (SUR): Serum testosterone
Study 19376495 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 19376616 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 19377166 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 19380866 — Predictive Biomarker (PRD): NFKBIA
Genes: IKBA; MAD-3; IkappaBalpha
Study 19394037 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19394037 — Surrogate Endpoint (SUR): Blood pressure
Study 19394543 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 19394543 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 19394543 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19394543 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 19394894 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 19402886 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 19402886 — Predictive Biomarker (PRD): IGFBP4 mRNA
Genes: IGFBP4; IBP4
Study 19402886 — Predictive Biomarker (PRD): IGFBP1 mRNA
Genes: IGFBP1; IBP1
Study 19402886 — Predictive Biomarker (PRD): IGFBP2 mRNA
Genes: IGFBP2; BP2; IBP2
Study 19402886 — Predictive Biomarker (PRD): F10 mRNA
Genes: F10
Study 19402886 — Safety Biomarker (SAF): Connecting peptide
Genes: AHSG; FETUA; PRO2743
Study 19402886 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 19402886 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 19402886 — Predictive Biomarker (PRD): MMP2 mRNA
Genes: MMP2; CLG4A
Study 19406978 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 19407319 — Surrogate Endpoint (SUR): Bone mineral density
Study 19407658 — Surrogate Endpoint (SUR): Blood pressure
Study 19407658 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19415121 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 19415121 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 19415121 — Predictive Biomarker (PRD): UIMC1 mRNA
Genes: UIMC1; RAP80; RXRIP110
Study 19421322 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 19423725 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study 19432972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19440247 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 19440247 — Surrogate Endpoint (SUR): Bone mineral density
Study 19443656 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19443658 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 19443658 — Predictive Biomarker (PRD): MLLT10 mRNA
Genes: MLLT10; AF10
Study 19450141 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 19450141 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19451441 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 19451441 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 19453788 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 19457240 — Surrogate Endpoint (SUR): Serum creatinine
Study 19457253 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 19457253 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19457253 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 19458012 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 19458352 — Predictive Biomarker (PRD): IL12A mRNA
Genes: IL12A; NKSF1
Study 19458352 — Predictive Biomarker (PRD): IL12RB2 mRNA
Genes: IL12RB2
Study 19458352 — Predictive Biomarker (PRD): STAT4 mRNA
Genes: STAT4
Study 19458352 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 19458352 — Safety Biomarker (SAF): HLA-DQB1
Genes: IDDM1; CELIAC1
Study 19458352 — Safety Biomarker (SAF): Interleukin 12
Study 19459850 — Predictive Biomarker (PRD): TTK mRNA
Genes: TTK; MPS1; MPS1L1
Study 19459850 — Predictive Biomarker (PRD): LY6K mRNA
Genes: LY6K; CO16
Study 19464412 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19466962 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19467341 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 19470620 — Surrogate Endpoint (SUR): Serum calcium
Study 19470888 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 19470888 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19483644 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 19488737 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 19493369 — Predictive Biomarker (PRD): INPP5K mRNA
Genes: INPP5K; PPS; SKIP
Study 19494218 — Predictive Biomarker (PRD): IL1RN mRNA
Genes: IL1RN; IL1F3; IL1RA
Study 19506561 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study 19507171 — Predictive Biomarker (PRD): GATC mRNA
Genes: GATC; 15E1.2
Study 19509175 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 19515473 — Surrogate Endpoint (SUR): Blood pressure
Study 19529780 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19529780 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 19531247 — Predictive Biomarker (PRD): BMPR2 mRNA
Genes: BMPR2; PPH1
Study 19535054 — Surrogate Endpoint (SUR): Serum creatinine
Study 19539144 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 19539214 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19540516 — Predictive Biomarker (PRD): PKHD1 mRNA
Genes: PKHD1; FCYT; TIGM1
Study 19540952 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 19542735 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 19546476 — Predictive Biomarker (PRD): DAPK1 mRNA
Genes: DAPK1; DAPK
Study 19546476 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19546476 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study 19553641 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 19553641 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 19556425 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 19556425 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 19557149 — Surrogate Endpoint (SUR): Blood pressure
Study 19562254 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 19562254 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 19562254 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 19565495 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19567517 — Surrogate Endpoint (SUR): Bone mineral density
Study 19569973 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 19573495 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 19576329 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19576664 — Surrogate Endpoint (SUR): Blood pressure
Study 19587341 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19587528 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19587528 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 19593212 — Predictive Biomarker (PRD): NPY1R mRNA
Genes: NPY1R; NPYR; NPYY1
Study 19593212 — Predictive Biomarker (PRD): NPY2R mRNA
Genes: NPY2R
Study 19593212 — Predictive Biomarker (PRD): NPY5R mRNA
Genes: NPY5R; NPYR5
Study 19593212 — Predictive Biomarker (PRD): SFRP2 mRNA
Genes: SFRP2; FRP2; SARP1; FKSG12; UNQ361/PRO697
Study 19593212 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study 19593212 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study 19593212 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study 19594946 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 19594946 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19594946 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 19602710 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 19604722 — Surrogate Endpoint (SUR): Pathological complete response
Study 19608747 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19615672 — Predictive Biomarker (PRD): MAOA mRNA
Genes: MAOA
Study 19616281 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 19620516 — Surrogate Endpoint (SUR): Blood pressure
Study 19621454 — Surrogate Endpoint (SUR): Serum creatinine
Study 19628656 — Predictive Biomarker (PRD): PMAIP1 mRNA
Genes: PMAIP1; NOXA
Study 19628656 — Predictive Biomarker (PRD): NADPH oxidase activator 1
Genes: NOXA1; P51NOX
Study 19633200 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 19633200 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 19635999 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study 19636010 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 19640291 — Surrogate Endpoint (SUR): Blood pressure
Study 19640956 — Surrogate Endpoint (SUR): Bone mineral density
Study 19643983 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 19643983 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 19643983 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study 19652055 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 19652067 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 19652199 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 19652201 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19654407 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study 19654407 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 19654407 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 19654407 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study 19657114 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 19663124 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 19663708 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19663708 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 19664276 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 19666119 — Surrogate Endpoint (SUR): Blood pressure